| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.97B | 137.12B | 132.88B | 136.03B | 124.31B | 123.65B |
| Gross Profit | 43.05B | 43.18B | 41.72B | 40.48B | 37.61B | 37.98B |
| EBITDA | 12.09B | 16.04B | 10.92B | 12.53B | 11.90B | 9.77B |
| Net Income | 3.21B | 6.28B | 5.11B | 4.50B | 2.94B | 2.15B |
Balance Sheet | ||||||
| Total Assets | 158.63B | 159.68B | 161.97B | 165.93B | 158.22B | 159.63B |
| Cash, Cash Equivalents and Short-Term Investments | 10.02B | 10.54B | 10.82B | 11.55B | 14.47B | 9.72B |
| Total Debt | 15.81B | 8.86B | 9.21B | 16.09B | 10.68B | 17.39B |
| Total Liabilities | 46.63B | 38.69B | 41.51B | 48.24B | 43.43B | 44.45B |
| Stockholders Equity | 110.24B | 119.19B | 118.77B | 115.88B | 113.03B | 113.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.06B | 2.79B | -9.02B | 3.80B | 3.71B |
| Operating Cash Flow | 0.00 | 11.57B | 10.41B | 1.79B | 9.15B | 8.60B |
| Investing Cash Flow | 0.00 | -7.49B | -190.00M | -5.92B | 6.81B | 1.17B |
| Financing Cash Flow | 0.00 | -5.18B | -11.35B | 1.01B | -12.36B | -9.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥140.61B | 15.30 | ― | 1.79% | 10.76% | 54.82% | |
78 Outperform | ¥173.29B | 9.78 | 10.24% | 2.43% | 6.08% | 8.55% | |
66 Neutral | ¥116.91B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥224.38B | 39.72 | 5.31% | 2.29% | -6.04% | 146.54% | |
58 Neutral | ¥1.73T | 117.21 | 3.37% | 1.85% | -2.18% | 26.45% | |
57 Neutral | ¥16.57B | -14.15 | ― | ― | 4.15% | -289.87% |